chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt. cried then stopped. held breath, turned red arm and head where loose after aminate pt. cried again.
0200 - very irritable. 0700 - woke up with hives all over body.  Especially in armpits, groin, hands, knees and face. 0800- presented at pediatrician. Cleared up with two days of Zyrtec.
Fever up to 104 for 48 hours, started about 4 hours after DTaP and Comvax were given. 3 episodes of diarrhea on 1st day. Mild tonsillitis on exam.
< 10 cm erythema and induration with central bruising whchich developed around 24 hours after the vaccinationand progressed. The patient was seen 3 days after; afebrile with no evidence of itching, ; no wheezing, no stridor was appreciated. Tenderness was present though the patient was still running in the office.
Had  Janssen  Covid 19  vaccine  5/3/21  on 5/12/21       Urticaria started face   Dermatographic Urticara    dx on 5/13                                Just diagnosed.
Initial report received from a healthcare professional (pharmacist) on 09 December 2013. This case is linked with cluster cases: 2013SA131895 and 2013SA131928 (Same vaccine, same reporter). A female patient, whose medical history and concomitant medications were not reported, had received a dose of influenza QIV vaccine (manufacturer: not provided, lot number, dose number, route and anatomical site of administration were not reported) on an unspecified date. The patient was pregnant at the time of vaccination. Her last menstrual period and estimated delivery date were not reported. On an unspecified date after vaccination, the patient developed Guillain Barre syndrome and had to deliver baby early. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of the event was unknown. Documents held by sender: none.
I started with chills at 7 pm went to bed at 9pm at 3:30 I had to go to bathroom and almost fell off toilet.  Caught myself but laid on floor and slept 30 min until I could get up and go back to bed.  Chills were gone at this time.   This morning at 10:30 I went to bathroom and blacked out.  I was laying on floor but don?t remember what happened except I must have twisted my ankle and knee as they are very sore.  I could not get up , no strength and hollered for Alexa to call my husband in the other part of the house.   I rested in bed and finally came  to couch and then around 3 ate a little but not hungry.  I feel better, took a bath and resting but have a terrible headache.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: shaking (seizure?)-Mild
Went to bed, was freezing.  My hands & arms were shaking so bad I couldn't hold the thermometer which was 97.  It lasted a half an hour & I got better.  I did go to hospital, but sat in car in parking lot with 80 degrees heater, heated seat & coat on.  My shaking calmed down.  No other symptoms.  I never had chicken pox & was reluctant to get this, but my doctor said to.  My husband also had a shot with me, but he just had a sore arm.  Afraid to get second shot!
got COVID after the COVID-19 Vaccines; got COVID after the COVID-19 Vaccines; This is a spontaneous report received from contactable reporter(s) (Nurse).  An 82-year-old male patient received BNT162b2 (BNT162B2), on 31Oct2021 as dose 1, single (Lot number: 301558A), in left arm, on 01Nov2021 as dose 2, single (Batch/Lot number: unknown) and on 31May2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 82 years for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing), notes: High cholesterol; "prostate" (unspecified if ongoing), notes: prostate. Concomitant medication(s) included: CRESTOR taken for blood cholesterol; FLOMAX RELIEF taken for prostate cancer; MUCINEX DM. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Jun2022, outcome "unknown" and all described as "got COVID after the COVID-19 Vaccines". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional Information: She is a registered nurse that does hospital audits for car accident cases. She thinks her father had rebound COVID too but he was never tested so she can't be sure. Her father was also told not to take his Crestor.  Paxlovid: She states her father had the same dose she was taking. NDC, lot number, and expiration date: unknown as her father threw the box out.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information and the known product safety profile a causal relationship between the reported events, COVID 19, Drug Ineffective and BNT162B2 is considered possible.
11/05/2019  Right arm painful , hurt to move it.  The actual injection site felt numb. Slept very poorly, felt like she was in a twilight sleep ,  felt odd almost felt disoriented.  Woke up next morning 11/06/2019 with a stiff neck and pain , could hardly move neck and noticed lymph nodes on left side of upper chest and neck were swollen. This lasted about 24 hours.  11/12/2019 Starting to feel better, but continue to feel  sore and stiff.
Information was received from a registered nurse concerning a 26 year old female patient who received the following altered dosing schedule for GARDASIL 9 intramuscularly (dosage not provided): First dose of GARDASIL 9, lot #M011117, expiration date 07-DEC-2017 administered on 13-SEP-2016. Second dose of GARDASIL 9, lot #L043214, expiration date 30-AUG-2017 administered on 14-DEC-2016. Third dose of GARDASIL 9, lot #M035486, expiration date 05-JUN-2019 administered on 14-FEB-2017. No adverse effects noted. Additional information has been requested.
A report was received from a health professional on 08Nov01, concerning a 48 year old female pt who experienced muscle spasms and wrist pain, 1 day after receiving the Fluvirin vaccine on 25Oct01. On 25Oct01, the pt experienced muscle spasms bilaterally in the arms and legs and wrist pain, 1 day receiving the Fluvirin vaccine. The pt was not treated at the time of event. At time of report, the symptoms had decreased but the pt had not recovered. The reporter has assessed the relationship of the study medication to the event as not known.
left side of my face along to jaw line felt funny when I swallowed then that side of my face along the jaw line became swollen as if I had a bad tooth it lasted for about 20 went down a little but when my daughter go home around 5pm it had swollen up again  as if someone socked me.   It went down before I went to bed around 9pm
Arm was a little sore; Shoulder pain due to a cyst that ruptured; muscle weakness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LZ0A) for COVID-19 vaccination.     Concurrent medical conditions included BRCA1 gene mutation since 07-Apr-2014.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore) and ARTHRALGIA (Shoulder pain due to a cyst that ruptured) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Magnetic resonance imaging: normal (normal) Minimal disc bulge at C5-C6 without evidence of spinal canal stenosis or neuroforaminal narrowing. The remainder of cervical spine is within normal limits.. On 08-Jan-2021, Magnetic resonance imaging: abnormal (abnormal) Posterosuperior through superior labral tear..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-016650 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Height, weight, race and ethnicity of patient were added. Medical history added. Dose 1 and dose 2 details were added. On 01-Jun-2021: MRI details added.
Within 5 minutes of receiving the vaccine, my heart began racing fast & hard,  hyperventilating, out of breath, uncontrollable full body tremors/shaking, severe brain fog.  Lasted for approximately 45 minutes.  Got back in my car to leave & it happened again.  Second episode lasted about 30 minutes.  The brain fog is still with me.
This case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who receive SHINGRIX (batch number XC534, expiry date 4th July 2020). On 5th March 2018, the patient received SHINGRIX. On 5th March 2018, less than a day after receiving SHINGRIX, the patient experienced chills, injection site pain and general body pain. In March 2018, the patient experienced fever, nocturnal awakening, muscle pain, fatigability generalized, headache and injection site erythema. In March 2018, the outcome of the nocturnal awakening, fatigability generalized and headache were recovered/resolved. On an unknown date, the outcome of the fever, chills, muscle pain, injection site erythema, injection site pain and general body pain were unknown. It was unknown if the reporter considered the fever, chills, nocturnal awakening, muscle pain, fatigability generalized, headache, injection site erythema, injection site pain and general body pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. After receiving SHINGRIX vaccine, the patient experienced the fever fluctuating from normal to 101 and back, severe chills with intense shivering that awoke the patient several times during 3 nights, body and muscle aching, general fatigue and mild headache for 72 plus hours and redness, soreness and mild pain at the injection site. The patient commented that it was okay if she developed immunity to shingles but that that left her with two questions. One was what should she expect as side effects from the second dose and what counselling they should give to their patients. They did not want to alarm them but the reporter was a little frightened by her side effects She further asked if they just warn them of the probable side effects and suggest mild acetaminophen dosing and what if any warnings should they make prior to the second dose especially for herself. The patient also mentioned that if the first available shingle vaccine was any indication they, as pharmacist, would be giving a great many of these vaccines. The patient called medical information requesting information about how to proceed. The patient's husband, also a pharmacist experienced the same side effects but much less severe (US2018GSK046333).
Client reports noticed starting getting red on 10/13/15 on the back LA where got shingles shot. It is sore and itches. No improvement or change since first day received immunization. Encourage cool compress and BENADRYL and/or Ibuprofen for itching or soreness. Client to see MD as needed if desires or if no improvement.
Patient is receiving the FSME (TBE) series. He had #1 11032017, #2 02122018. He was supposed to get the #3 5 months after second dose but instead the #3 dose was mistakenly given on 04122018 (Thursday). Mom claimed that patient vomited night of Sunday, April 15 and was really tired the following day.
Patient called to say her arm became very hot and hard and she had fever the evening of injection. Stated she felt nausea but did not get sick. She took 2 ibuprofen and went to bed and called the pharmacy this morning. She stated she felt better but her arm was still hot and hard at injection site but she did not want to go to Dr. just wanted to let us know and will take more ibuprofen. I told her to contact her Dr. if she felt worse. She stated she was better and no trouble breathing.
Bacterial infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACTERIAL INFECTION (Bacterial infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACTERIAL INFECTION (Bacterial infection). The patient was treated with CEFALEXIN (CEPHALEXINE) (oral) at a dose of 500 milligram three times a day. At the time of the report, BACTERIAL INFECTION (Bacterial infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient started with oral medication, cephalexin 500mg, 3 times a day for ten days for a bacterial infection.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (strength, dose, lot#, expiration date and route were unknown). It was reported that the healthcare worker was attempting to report a product complaint with ZOSTAVAX, but due to technically difficulties the call was disconnected before further information could be provided. It cannot be ruled out that an adverse event with ZOSTAVAX was associated with the product complaint. Product quality complaint was filled. The outcome of the events was unknown. Additional information has been requested.
Right arm swollen, red and painful post flu vaccine received 10/20/16. Affected area 2.5 in x 5 in. Afebrile. Treated with ibuprofen and BENADRYL.
Rash right arm day after tetanus booster, lasted 10 days so far U/C antihistamine now resolving. local induration R arm.
very sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick). At the time of the report, ILLNESS (very sick) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications information not provided. Treatment medications information not provided   This case was linked to MOD-2021-129280, MOD-2021-153078 (Patient Link).
Initially, I had my throat felt closed but I drank a lot of water. The next day I felt like a bag of rocks. Last week, I had a huge bump inside of my neck. Today, my shoulder and neck hurt a lot very painful. I'm wondering if going to seek medical help would even be useful.
Information has been received from a physician concerning his 7 year old daughter who on 10-Oct-2007, was vaccinated with PROQUAD (lot #657186/0302U).  Concomitant vaccination included PREVNAR (batch 3 B26510D.  On 14-Oct-2007, developed a rash all over, low grade fever, and was cranky.  It was reported that the vaccinating pediatrician was aware and the patient recovered.  A product quality complaint was not reported.  Further information was not available.  Additional information has been requested.
Mom was pregnant post exposure rabies series which started in 8-1. After 1st dose and continued following every shot. 15 mins after injection "puked" lasted 1/2 hr-45 mins. After 2nd dose, pain arm and still gets muscle knots in forearm. Knots turned black and blue. Spasms in legs and arms after 3nd series.
Pt cried x 2 hrs, inc temp, nausea, vomiting; Pt taken to MD- MD not in pt fine next day;
Day after 2nd dose, discomfort stayed in bed. 2nd day after dose shoulder pain radiating to chest, during night intense chest pain with extremely shallow breathing. By morning chest pain so bad I went to E.R. I was admitted with normal EKG and oxygen levels. Elevated test that indicates blood clot in lung. CT scan done. Diagnosis Pulmonary Embolism. Was admitted to hospital for 2 days while undergoing heparin and warfarin therapy and pain relief. Prescribed blood thinners for 6 mos. After release severe fatigue and low HGB levels limited walking of more than 50' without losing consciousness. It has been 1 month and still can only walk 100' without lightheadedness.
Severe dizziness (vertigo-like), lasting approximately 30-60 seconds every few days starting 2 weeks after first dose.
INJECTION FELT LIKE A DRILL AND HURT CONSIDERABLY. COULD NOT SLEEP ALL NIGHT, WITH CHILLS, A HEADACHE AND SLIGHT NAUSEA. THE FOLLOWING DAY LOST MY APPETITE COMPLETELY AND WAS EXTREMELY LETHARGIC. INJECTION SITE WAS SWOLLEN AND RED AND THE SIZE OF A LARGE BASEBALL. AFTER 4 DAYS STARTED ITCHING AND NOW AM 95% BETTER. THIS WAS THE 2ND IN THE SERIES OF SHOTS, FIRST ONE DONE JAN. 16, 2018, ARM HURT, BUT NO MAJOR ILL EFFECTS.
Horrible sinus infection, dizziness, ear pain, overall malaise feeling, temps > 100 degrees F.
Dizziness after second vaccine dose; Looses balance, but not in a bad shape after second vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness after second vaccine dose) and BALANCE DISORDER (Looses balance, but not in a bad shape after second vaccine dose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced DIZZINESS (Dizziness after second vaccine dose) and BALANCE DISORDER (Looses balance, but not in a bad shape after second vaccine dose). At the time of the report, DIZZINESS (Dizziness after second vaccine dose) and BALANCE DISORDER (Looses balance, but not in a bad shape after second vaccine dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021:
Patient report arm swelling and tightness same day.  Around day 5 or so developed body aches and achy joints and rash. She called the office and had was seen by another physician and given prednisolone.
The day after patient received the Pfizer COVID-19 vaccine, her mother stated she developed bilateral redness on her arms and across her chest. The mother denied having any raised bumps noted on her daughter's skin. Patient stated the red areas were a little itchy. On the third day after  the vaccination, she also developed a similar red rash on her legs. Her mother stated the symptoms resolved the afternoon of the third day after receiving the Pfizer COVID-19 vaccine. The patient and her mother denied experiencing any dizziness, shortness of breath, symptoms of anaphylaxis or other signs. No treatment administered for the rash. The patient's mother gave her  Tylenol for arm pain. No follow-up with any physicians. The patient has no chronic medical conditions, medications or known allergies.
Almost immediately following dose 1 of Lymerix, the pt began to experience arthritis symptoms in her knees and hips. These symptoms resolved. She experienced flu-like symptoms and a low grade fever. These symptoms resolved. She experienced lethargy, depression, cervical pain, left eye vision, cloudiness and decreased hearing. These symptoms are ongoing. On 3/22/00, six months post dose 2, she experienced Bell's Palsy. Her primary physician and neurologist "did not address if this was related to Lymerix." In 4/00 seven months post vax she developed shingles. Her physicians did not address if this was related. On 6/21/00, she received her third dose of Lymerix. As of 10/27/00, the outcome of the events is ongoing.
pt recv vax 16APR97 & 17APR97 pt devel redness & swelling @ the inj site & down to the elbow from deltoid area;inc temp to 99-100 & generally didn't feel good;
had COVID in September 2021; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (had COVID in September 2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced COVID-19 (had COVID in September 2021). At the time of the report, COVID-19 (had COVID in September 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received antibody treatment around  09Sep2021 .  No concomitant treatment was reported This case concerns a female patient of unknown age, with no medical history reported, who experienced the unexpected non-serious adverse event of special interest of COVID-19. The event occurred approximately 7 months after the second dose of Moderna COVID-19 vaccine (exact date unknown). The rechallenge was not applicable since the event occurred after the second dose. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.; Sender's Comments: This case concerns a female patient of unknown age, with no medical history reported, who experienced the unexpected non-serious adverse event of special interest of COVID-19. The event occurred approximately 7 months after the second dose of Moderna COVID-19 vaccine (exact date unknown). The rechallenge was not applicable since the event occurred after the second dose. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.